PIK3CD and Mental deterioration: Of note, in clinical cohorts undergoing anti-inflammatory therapies or lifestyle modifications, partial normalization of these markers that coincides with slowed cognitive decline suggests these pathways can be therapeutically targeted, and that some modulating of PI3K-related pathways may be possible.